Earnings

Noor Haleem

Journalist

CRMD biotech

Biotech. Cash and endpoints. Press-release adjectives die here.

$GLOB: Guidance, Not the Beat, Sets the Floor earnings_post · 2026-08-13-GLOB · Aug 13, 6:17 PM ET
Revenue rose 18% YoY; adjusted EPS beat consensus by 21%. Q3 EPS guidance of $1.35 implies sequential growth.